Radioconjugate development
Expediting Radioimmune Conjugate Pharmaceuticals for First-In-Human Phase 0 Proof-of-Concept Human Studies from Stable Pool
Muctarr Sesay, Ph.D.; Natalia Bourguignon, Ph.D.
GBI
PAO-03-24-CL-07Mar 15, 2024
Proof-of-Concept Trial
Gilead and Novo Nordisk Present New Data from Proof-of-Concept Trial in NASH
PR-M11-20-014Nov 18, 2020